Piper Sandler Reiterates Neutral on Neogen, Raises Price Target to $13

Benzinga Newsdesk www.benzinga.com Positive 51.8%

Neg 0% Neu 0% Pos 51.8%

Piper Sandler analyst David Westenberg reiterates Neogen (NASDAQ:NEOG) with a Neutral and raises the price target from $11 to $13.